Brazil announced that they are suspending the $324 million deal for Bharat Biotech’s Covaxin as there are concerns around irregularities in the procurement process. Brazilian President Bolsonaro is being accused of overlooking possible corruption in a deal to purchase coronavirus vaccines. Brazilian federal prosecutors have opened an investigation into the deal, citing comparatively high prices, quick talks and pending regulatory approvals […]
Bharat Biotech’s Covid vaccine Covaxin effectively neutralises both Alpha and Delta variants of coronavirus, the US’ National Institute of Health has said. The top American health research institute said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the Alpha variant that […]
New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources.
Pennsylvania [US], June 11 (ANI): Bharat Biotech's US partner Ocugen Inc said that the company will no longer pursue an Emergency Use Authorization (EUA) for COVAXIN and the US Food and Drug Administration (FDA) has recommended that the company go for the Biologics Licence Application (BLA) route, which is for full approval, with additional data.
New Delhi [India], June 9 (ANI): The Central Industrial Security Force will take over security of the Hyderabad campus of Bharat Biotech, one of the major COVID-19 vaccine manufacturers in the country, informed CISF on Tuesday.